neurofibromatosis
Information
- Disease name
- neurofibromatosis
- Disease ID
- DOID:8712
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00508235 | Completed | Quality of Friendships in Children With Neurofibromatosis | December 2004 | July 2009 | |
| NCT00589784 | Completed | Phase 2 | Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma | October 2007 | October 2014 |
| NCT02101736 | Completed | Phase 2 | Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 in Children and Adults | June 2014 | February 16, 2022 |
| NCT02211768 | Completed | Phase 1 | Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 | December 8, 2014 | December 30, 2019 |
| NCT02298270 | Completed | N/A | Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With Skype | March 2014 | July 2015 |
| NCT02435628 | Completed | Relationship Between Psychosocial Factors, Health Literacy, Quality of Life and Satisfaction With Medical Visits in Adults With NF | February 2015 | September 2016 | |
| NCT00754780 | Completed | Phase 2 | Clinical Trial of Pirfenidone in Adult Patients With Neurofibromatosis 1 | September 2000 | |
| NCT01140360 | Completed | Phase 1/Phase 2 | Pilot Study of Gleevec/Imatinib Mesylate (STI-571, NSC 716051) in Neurofibromatosis (NF1) Patient With Plexiform Neurofibromas | February 2012 | December 2016 |
| NCT01275586 | Completed | Early Phase 1 | Study of Tasigna®/Nilotinib (AMN107) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas | January 2011 | October 2016 |
| NCT01633008 | Completed | Early Phase 1 | Acceptance and Commitment Therapy for Adolescents and Young Adults With Neurofibromatosis and Chronic Pain | June 15, 2012 | January 10, 2017 |
| NCT01639950 | Completed | Validating Pain Scales in Children and Young Adults | August 6, 2012 | ||
| NCT01673009 | Completed | Phase 2 | Phase II Study of Gleevec/Imatinib Mesylate (STI-571, NCS 716051) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas | May 2006 | August 2012 |
| NCT00598351 | Recruiting | Natural History Study of Patients With Neurofibromatosis Type 2 | March 21, 2008 | ||
| NCT04463316 | Recruiting | GROWing Up With Rare GENEtic Syndromes | October 1, 2018 | January 1, 2030 | |
| NCT01402817 | Terminated | Phase 2 | Study of Sutent®/Sunitinib (SU11248) in Subjects With NF-1 Plexiform Neurofibromas | March 2012 | February 14, 2018 |
| NCT04461886 | Terminated | Phase 3 | A Long-term Study of NPC-12G Gel in Neurofibromatosis Type I | July 8, 2020 | December 7, 2021 |
- Disase is a (Disease Ontology)
- DOID:0080690
- Cross Reference ID (Disease Ontology)
- GARD:10420
- Cross Reference ID (Disease Ontology)
- ICD10CM:Q85.0
- Cross Reference ID (Disease Ontology)
- ICD9CM:237.7
- Cross Reference ID (Disease Ontology)
- MESH:D017253
- Cross Reference ID (Disease Ontology)
- NCI:C6727
- Cross Reference ID (Disease Ontology)
- ORDO:634518
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:19133005
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0162678
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0495632